US states wringing their hands at empty cupboards left by the Trump administration will be getting a 17 per cent boost in Covid-19 vaccine supply next week.
Latest figures updated on the Centers for Disease Control and Prevention (CDC) website Tuesday show that the Biden government plans to make about 10.1 million first and second doses of both the Pfizer and Moderna vaccines available next week, up from this week's allotment of 8.6 million.
States have cancelled thousands of appointments over the last week because their supply ran out right around the time Joe Biden was inaugurated.
The Biden administration inherited multiple bottlenecks and shortages, although Pfizer and Moderna have committed an initial 100 million doses each. aceI can't tell you how much vaccine we have," incoming CDC director Dr. Rochelle Walensky told Fox News. "And if I cana¿t tell it to you, then I can't tell it to the governors, and I can't tell it to the state health officials."
Biden plans to update Americans on the country's vaccine stockpile Tuesday, press secretary Jen Psaki said. The White House is also bringing back Covid-19 briefings three times a week.
As of Tuesday, the federal government has distributed 44.3 million vaccine doses to states. Of that, 23 million doses, or over 52 percent have been administered. About 3.4 million people have received their full two-dose vaccination, and more than 19 million have got their first dose, according to data from the CDC.
The coronavirus has killed more than 421,000 Americans and infected more than 25 million since the first case was reported on January 21, 2020. Biden is hoping to get at least 100 million Americans vaccinated in the first 100 days of his government. He is holding out a sense of cautious optimism that any American who wants the vaccine could possibly get it "this Spring."
(Nikhila Natarajan can be reached at nikhilanatarajan@gmail.com)
--IANS
niki/rs
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU